FDA Ordered to Release New Drug Records

The National Law Review has this article on the U.S. District Court for the Central District of California's recent decision ordering the FDA to release new drug records even though the FDA had argued that they were protected pursuant to Exemption 4 of the FOIA.  The article is authored by two attorneys from Mintz Levin.